ANTI-EGFR SINGLE-CHAIN FV, CHIMERIC ANTI-EGFR ANTIBODY AND METHOD OF ITS PREPARING, PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATIENTS WITH TUMORS, AGENT FOR DIAGNOSIS OF LOCALIZATION AND ESTIMATION OF TUMOR GROWTH Russian patent published in 2001 - IPC

Abstract RU 2170257 C2

FIELD: genetic engineering of proteins, medicine, oncology, pharmacy. SUBSTANCE: invention relates to novel anti-EGFR antibodies and their single-chain Fv-fragments that can be prepared from library phage-antibody constructed from mammal immunized cells, preferably, from mouse. Two single-chain Fv isolated from library phage-antibody are treated by methods of genetic engineering to create molecules of partially humanized complete antibody. These chimeric anti-EGFR antibodies have constant regions of human immunoglobulins and can be used as well as their single-chain Fv as agents for diagnosis and treatment of humans with tumors. EFFECT: new antibodies indicated above, valuable medicinal properties. 9 cl, 5 tbl

Similar patents RU2170257C2

Title Year Author Number
ANTI-IDIOTYPICAL ANTIBODIES THAT INDUCE IMMUNE RESPONSE AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR 1996
  • Karsel'Er Ana
  • Rosel' Ehlizabet
  • Gomes Alisija
  • Adan Khaume
  • P'Julats Khaume
RU2172636C2
MODIFIED ANTI-EGFR ANTIBODIES WITH REDUCED AMMONOGENICITY 2002
  • Karr Frehnsis Dzh.
  • Karter Grehm
  • Dzhons Tim
  • Uill'Jams Stiven
  • Khamil'Ton Anita
RU2297245C2
BISPECIFIC ANTIGEN MOLECULE FOR LYSIS OF TUMOR CELLS, METHOD FOR PREPARING F(AB')2 FRAGMENT OF BISPECIFIC ANTIGEN MOLECULE, MONOCLONAL ANTIBODY (VERSIONS), PHARMACEUTICAL PREPARATION, PHARMACEUTICAL KIT FOR LYSIS OF TUMOR CELLS (VERSIONS), METHOD OF LYSIS OF TUMOR CELLS EX VIVO IN AUTOGENOUS BONE MARROW TRANSPLANTATION 1994
  • Shtrittmatter Vol'Fgang
  • Jeggle Karlota-Sil'Via
  • Mojer Shtefan
  • Burkkhart Shraven
  • Vil'D Martin
RU2203319C2
IMMUNOCONJUGATES, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION 1995
  • Vol'Fgang Khel'Tser
  • Ilka Fon Khoegen
  • Vol'Fgang Shtrittmatter
  • Zigfrid Mattsku
RU2157701C2
IMMUNOCONJUGATE, A METHOD OF AN IMMUNOCONJUGATE PREPARING AND A PHARMACEUTICAL COMPOSITION 1994
  • Ilka Fon Khegen
  • Uve Khofmann
  • Karlotta-Sil'Vija Eggle
  • Vol'Fgang Shtrittmatter
  • Jorg Shtadl'Mjuller
  • Zigfrid Mattsku
RU2129018C1
HIGH-CONCENTRATION LIQUID ANTI-EGFR ANTIBODY COMPOSITIONS 2005
  • Mateus Zuzanne
  • Maler Khanns-Kristian
RU2390353C2
SOLID FORMS OF ANTI- EGFR ANTIBODIES 2004
  • Mateus Zuzanne
  • Maler Khanns-Kristian
RU2397755C2
PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS 2003
  • Krejsh Khans-Georg
  • Shmidt Jurgen
RU2354402C2
MONOCLONAL ANTIBODY RAISED AGAINST αV-INTEGRINS (VARIANTS), ITS PREPARING (VARIANTS) AND USING, HYBRIDOMA, POLYPEPTIDE, DNA 1995
  • Mitkhans Fransesk
  • Piulats Khaume
  • Rosel' Ehlizabet
  • Adan Khaume
  • Gudman Sajmon
  • Khan Dajane
RU2205223C2
COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS 2001
  • Gudman Sajmon
  • Krejsh Khans-Georg
RU2292904C2

RU 2 170 257 C2

Authors

A. Kehtrin Kettleboru

Mehri M. Bendig

Kejt Kh. Ehnsell

Detlef Gjussov

Khaume Adan

Fransesk Mitkhans

Ehlizabet Rossel'

Fransesk Blasko

Khaume Piulats

Dates

2001-07-10Published

1995-03-16Filed